Cleveland’s wide receivers dropped 25 passes in 2025, finishing with a league-low catch rate of around 50 percent. It seems ...

Discover seven AI tools that help students study smarter in 2026. From Brighterly’s 1:1 tutoring to AI-powered notes, ...

Life insurance is an asset class that requires a diversified portfolio approach like any other — here's what that means for ...

The secondary market in venture capital is growing as companies stay private for longer, yet the market is extremely ...

A calm classroom may look successful, but some of the quietest students are retreating from safety, support, and a sense of ...

GPT-5.4 Pro cracked a conjecture in number theory that had stumped generations of mathematicians, using a proof strategy that ...

Researchers have, for the first time, described the properties of one-dimensional anyons and outlined how these particles can be observed using existing experimental setups.

We consider Structure Therapeutics as one of the most compelling risk-reward setups in the biotechnology sector and an attractive M&A candidate. The company's oral small molecule GLP-1 receptor ...

There have been some notable flops among companies that gave founders extra voting power, insulating them from outside pressure. Allbirds is the latest. In my latest Markets A.M. newsletter, I look at ...

Following pressure from parents, the Karnataka government on Thursday announced a 60-day relaxation in the age eligibility criteria for class 1 admissions for the 2026–27 academic year. Minister for ...

From April 1, 2026, the implementation of the Income Tax Act, 2025 and Income Tax Rules, 2026 could change the way your salary is structured, even if your total cost-to-company (CTC) remains the same.

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...